Glenmark Pharmaceuticals s.r.o. operates as the Czech market entity of Glenmark Pharmaceuticals Ltd., a global pharmaceutical group with in-house research and development, manufacturing and international commercialization capabilities. The Czech business focuses on registration, marketing and distribution of pharmaceutical products, including prescription medicines, over-the-counter products, dietary supplements, medical devices and cosmetics. Activities are aligned with group-level therapeutic area strategies and product lifecycle management. The geographic scope is primarily domestic, integrated into a broader multinational supply and development network. Key assets include access to Glenmark's global product portfolio, regulatory expertise and brand equity. Strategic focus centers on expanding branded generics and healthcare solutions addressing unmet needs in targeted therapeutic segments.
Headquarters
Hvezdova 1716/2
Prague; The City of Prague;
Postal Code: 14000
Contact Details: Purchase the Glenmark Pharmaceuticals S.R.O. report to view the information.
Website: https://www.glenmarkpharma.cz/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service